BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$1.11
+0.28 (+33.73%)
Open$0.88
Previous Close$0.83
Day High$1.33
Day Low$0.85
52W High$10.05
52W Low$5.85
Volume—
Avg Volume505.9K
Market Cap5.44M
P/E Ratio45.96
EPS$0.16
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+583.8% upside
Current
$1.11
$1.11
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.16M | 1.19M | 1.27M |
| Net Income | -117,803 | -121,826 | -173,784 |
| Profit Margin | -10.2% | -10.2% | -13.7% |
| EBITDA | -246,829 | -223,977 | -272,889 |
| Free Cash Flow | -166,595 | -168,575 | -137,708 |
| Rev Growth | +16.9% | +20.6% | -0.4% |
| Debt/Equity | 0.36 | 0.44 | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |